Covaxin will begin on Wednesday in a special laboratory set up at the Institute of Medical Sciences and SUM (IMS & SUM) Hospital, in accordance with the protocols laid down by the Drugs Controller General of India (DCGI), the official at the facility said.The special laboratory -- Preventive and Therapeutic Clinical Trial Unit (PTCTU) -- was inaugurated at the institute on Monday by its dean Gangadhar Sahoo. "All necessary arrangements have been made for conducting the human trials.
We expect to start from Wednesday," Dr E Venkat Rao, the principal investigator of the trial process and professor of community medicine at the hospital, told PTI.The human trials of BBV152 COVID Vaccine or Covaxin will begin on Wednesday.